Activest Wealth Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$942 Hold
100
﹤0.01% 969
2026
Q1
$814 Hold
100
﹤0.01% 1040
2025
Q4
$672 Hold
100
﹤0.01% 981
2025
Q3
$867 Hold
100
﹤0.01% 891
2025
Q2
$630 Hold
100
﹤0.01% 833
2025
Q1
$641 Buy
+100
New +$827 ﹤0.01% 828
2022
Q2
Sell
-2
Closed 391
2022
Q1
$0 Hold
2
﹤0.01% 360
2021
Q4
$0 Hold
2
﹤0.01% 381
2021
Q3
$1K Hold
2
﹤0.01% 356
2021
Q2
$1K Hold
2
﹤0.01% 317
2021
Q1
$1K Buy
+2
New +$399 ﹤0.01% 289

Other funds holding NVAX

Activest Wealth Management's NVAX Position: Q2 2026 in Review

Activest Wealth Management held its Novavax (NVAX) position steady in Q2 2026 at 100 shares worth $942. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Activest Wealth Management first reported a position in NVAX in Q1 2021 and has held it in 11 quarters since. The position peaked at $1K in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Activest Wealth Management held 100 shares of Novavax worth $942 as of Q2 2026.
  • Activest Wealth Management left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #969 holding.
  • Activest Wealth Management first reported a position in Novavax in Q1 2021 and has held it in 11 quarters since.
  • Activest Wealth Management's Novavax position peaked at $1K in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.